Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 265-334-3 | CAS number: 65059-45-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian cell study: DNA damage and/or repair
- Remarks:
- Type of genotoxicity: DNA damage and/or repair
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 486 (Unscheduled DNA Synthesis (UDS) Test with Mammalian Liver Cells in vivo)
- Deviations:
- yes
- Remarks:
- The mortality check for animals was performed twice on 30 Nov 2015. This is a deviation from the protocol which required that the mortality check be performed once each day.
- Principles of method if other than guideline:
- Guideline followed
- GLP compliance:
- yes
- Type of assay:
- unscheduled DNA synthesis
Test material
- Reference substance name:
- 4,11-diamino-2-(3-methoxypropyl)-1H-naphth[2,3-f]isoindol-1,3,5,10(2H)-tetrone
- EC Number:
- 235-402-7
- EC Name:
- 4,11-diamino-2-(3-methoxypropyl)-1H-naphth[2,3-f]isoindol-1,3,5,10(2H)-tetrone
- Cas Number:
- 12217-80-0
- Molecular formula:
- C20H17N3O5
- IUPAC Name:
- 4,11-diamino-2-(3-methoxypropyl)-1H-naphtho[2,3-f]isoindole-1,3,5,10(2H)-tetrone
- Test material form:
- solid: particulate/powder
- Details on test material:
- None
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: ENVIGO, Frederick, MD
- Age at study initiation: 8 weeks
- Weight at study initiation: 222.3 - 259.8 g
- Housing: Micro barrier cage
- Diet (e.g. ad libitum): Envigo 2018C Certified Global Rodent Diet ad libitum
- Water (e.g. ad libitum): Tap water (U.S. EPA drinking water standards) ad libitum
- Acclimation period: 6-9 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 72 ± 3 °F
- Humidity (%): 50 ± 20 %
- Air changes (per hr): 10 changes of fresh HEPA-filtered air per hour.
- Photoperiod (hrs dark / hrs light): 12-hour light/dark cycle
:
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: 1 %w/v methylcellulose in deionized water
- Concentration of test material in vehicle: Dose formulations were adjusted to compensate for the purity (91 %) of the test substance using a correction factor of 1.090. The dosing formulation was prepared at a concentration of 3.5 mg/mL, just prior to use.
- Amount of vehicle (if gavage or dermal): 70 % - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Dose formulations were adjusted to compensate for the purity (91 %) of the test substance using a correction factor of 1.090. Dose formulations were prepared fresh on each day of use. Each concentration was prepared by calibrating a suitable size amber vial with a PTFE stir bar to appropriate volume. An appropriate amount of the test substance was weighed out and then transferred into the calibrated formulation container and then the vehicle was added to the QS line and mixed magnetically until homogenous in appearance. The final dose formulation was stored at room temperature. Residual dose formulations were discarded after use.
All dose formulations were administered at a volume of 10 mL/kg by oral gavage using appropriately sized disposable polypropylene syringes with gastric intubation tubes (needles). The route has been routinely used and is widely accepted for use in the unscheduled DNA synthesis assay. - Duration of treatment / exposure:
- Only the high dose of 500 mg/kg at 2 to 4 hours and 12 to 16 hours harvest timepoints was evaluated for the UDS along with vehicle and positive controls.
- Frequency of treatment:
- All dose formulations were administered at a volume of 10 mL/kg by oral gavage using appropriately sized disposable polypropylene syringes with gastric intubation tubes (needles). The route has been routinely used and is widely-accepted for use in the unscheduled DNA synthesis assay.
- Post exposure period:
- None
Doses / concentrations
- Remarks:
- Doses / Concentrations:
150, 350, 500
Basis:
nominal conc.
- No. of animals per sex per dose:
- 4 animals/dose
- Control animals:
- yes
- Positive control(s):
- - Dimethylnitrosamine (DMN)
- Doses / concentrations: 35 mg/kg bw
Examinations
- Tissues and cell types examined:
- The methods used for isolation and culturing of hepatocytes are modifications of the procedures used by Williams (1976 and 1979). For preparation of hepatocyte cultures, each animal was anesthetized by inhalation of isoflurane and a midventral incision was made to expose the liver. The liver was perfused with 0.5 mM ethylene glycol-bis(β-aminoethyl ether) N,N,N',N' tetraacetic acid (EGTA) solution followed by collagenase solution (80-100 units Type I collagenase/mL culture medium). The liver was removed, transected, and shaken in a dilute collagenase solution to release the hepatocytes. The cells were pelleted by centrifugation, resuspended in complete Williams' Medium E (WME; buffered with 0.01 M HEPES, supplemented with 2 mM L-glutamine, 50 microg/mL gentamicin and 10 % fetal bovine serum). The cell viability for the vehicle control hepatocytes should be at least 70 % for use in the assay.
Approximately 5 x 10E5 cells were seeded into each of six 35 mm tissue culture dishes containing 25 mm coverslips and preconditioned complete WME (i.e., complete WME medium in 35 mm tissue culture dishes incubated overnight in a humidified atmosphere of 5±1% CO2 and 37±1°C). A minimum of 6 cultures was set up for each animal. The hepatocyte cultures were maintained in a humidified atmosphere of 5±1 % CO2 and 37±1 °C. - Details of tissue and slide preparation:
- Ninety to 180 minutes after plating, the cells were washed once with complete WME and serum-free WME containing 10 µCi 3H-thymidine/mL was added. Four hours later, the radioactive medium was removed; the cultures were washed 3 times in serum-free WME containing 0.25 mM thymidine, and then refed with serum-free WME containing 0.25 mM non-titrated thymidine and incubated for 17-20 hours.
Seventeen to 20 hours after completion of the exposure to thymidine, the coverslips bearing cultures were washed once in serum-free WME. The nuclei were swelled in 1% sodium citrate solution and the cultures fixed in 3 changes of ethanol-glacial acetic acid fixative (3:1, v/v). The coverslips were allowed to air dry for at least 1.5 hours before mounting cell side up on glass slides. Each slide was identified by the study number, group number and animal number. Slides were coded using a random number table by an individual not involved with the scoring process, whenever possible.
At least 3 of the 6 slides for each animal were dipped in photographic emulsion at 43 - 45 °C, allowed to drain and dry for at least 1.5 hours at room temperature and were stored for eight days at 2-8 °C in light tight boxes with desiccant. Slides were developed in Developer (diluted 1:1 in deionized water), fixed in Fixer, and stained with hematoxylin-eosin stain. - Evaluation criteria:
- Once the criteria for a valid assay were met, the results were evaluated as follows:
• Any mean net nuclear count that was increased by at least five counts over the negative control was considered significant (Butterworth et al., 1987).
• Test article was considered to be positive if it induced a dose related increase with no less than one dose significantly elevated above the negative control or if a significant increase in the mean net nuclear grain count in at least two successive doses was observed in the absence of a dose-response.
• The test substance was considered to be negative if no significant increase in the net nuclear grain counts was observed.
• The test substance was considered to be equivocal if there was a significant increase in the net nuclear grain count at the high dose only with no evidence of a dose-response or there was a significant increase in the net nuclear grain count at one dose level without a dose-response.
• Other criteria may have been used in reaching a conclusion about the study results (e.g., magnitude of any increase, dose-dependency, comparison to historical control values, biological significance, etc.). In such cases, the Study Director used sound scientific judgment and clearly reported and described any such considerations - Statistics:
- The slides were viewed microscopically under a 100X oil immersion lens. An automated colony counter was interfaced with the microscope so that silver grains within each nucleus and the surrounding cytoplasm could be counted. The ProtoCOL system with accompanying support software was used for grain counts. First, the number of grains in a nucleus was counted. Then, the number of grains in 3 separate nuclear-size cytoplasmic areas (taken from the area adjacent to the nucleus and which appeared to have the highest grain counts) was counted. The counts were captured directly by the software and stored as raw data in an electronic data file created by the software. Fifty nuclei were scored from each of three replicate cultures for a total of 150 randomly selected nuclei from each animal. Nuclei selected were surrounded by cytoplasm. A minimum of three animals per group were evaluated for UDS. Replicative DNA synthesis is evidenced by nuclei completely blackened with grains, and such cells were not counted. Cells exhibiting toxic effects of treatments, such as irregularly shaped or very darkly stained nuclei, were not counted. A net nuclear grain count was calculated for each nucleus scored by subtracting the mean cytoplasmic area count from the nuclear area count. For each animal as well as for each treatment group, a mean net nuclear grain count and standard deviation (S.D.), as well as the proportion of cells in repair (percentage of nuclei showing ≥5 net nuclear grain counts) were determined. The slides will be discarded prior to the finalization of the report.
Results and discussion
Test results
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- None
Any other information on results incl. tables
The following clinical signs were observed in the 12 to 16 hour harvest:
Dose Level (mg/kg bw) |
Males |
Vehicle |
Normal |
50 |
Normal |
350 |
Normal |
500 |
Normal |
Positive Control |
Diarrhea |
The results of the UDS assay using primary hepatocytes isolated 2 to 4 hours post-exposure are summarized:
Dose Level |
Net Nuclear Grain Count (Mean±SD) |
Cells in Repair (%) |
|
Vehicle: 1% w/v methylcellulose (medium viscosity) in deionized water |
-1.9±0.3 |
2 |
|
Test Substance: FAT 36152/M TE |
350 |
-1.6±0.5 |
2 |
500 |
-2.7±0.5 |
2 |
|
Positive Control: DMN 35 mg/kg |
18.9±0.4 |
98 |
The results of the UDS assay using primary hepatocytes isolated 12 to 16 hours post-exposure are summarized:
Dose Level |
Net Nuclear Grain Count (Mean±SD) |
Cells in Repair (%) |
|
Vehicle: 1% w/v methylcellulose (medium viscosity) in deionized water |
-1.8±0.8 |
2 |
|
Test Substance: FAT 36152/M TE |
350 |
-2.3±0.8 |
3 |
500 |
-1.7±1.2 |
3 |
|
Positive Control: DMN 35 mg/kg |
25.1±4.6 |
98 |
Applicant's summary and conclusion
- Conclusions:
- FAT 36152/M was concluded to be negative for the induction of unscheduled DNA synthesis in primary cultures.
- Executive summary:
FAT 36152/M was evaluated for its genotoxic potential to induce unscheduled DNA synthesis in primary cultures of hepatocytes obtained from test substance-treated rats according to OECD Guideline 486 (Unscheduled DNA Synthesis (UDS) Test with Mammalian Liver Cells in vivo). 1 % w/v methycellulose (medium viscosity) in deionized water was selected as the vehicle. Test and/or control article formulations were administered at a dose volume of 10 mL/kg by oral gavage only once. The definitive assay dose levels tested were 150, 350 and 500 mg/kg. Two harvest timepoints, 2 to 4 hours and 12 to 16 hours after dose administration were used for hepatocyte collection. Cells were processed and scored for the UDS assay. Only the high dose of 500 mg/kg with vehicle and positive control were scored and evaluated. No significant increase in average MNNGC ( mean net nuclear grain count) was observed at either harvest time. At both harvest times, the proportion of cells in repair in the vehicle control group was less than 15 %, the average MNNGC of the vehicle control group was less than 1, and the average MNNGC of the positive control group was at least 5 counts over that of the vehicle control group. Under the conditions of this study, the administration ofFAT 36152/M at a dose of 500 mg/kg bw was negative in the in vivo mammalian cell unscheduled DNA synthesis (UDS) assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.